Table 2. Pharmacokinetic Properties of Compounds 3, 4, and 5a in C57BL/6N Micea.
no. | F % | AUCN po (μM h/mg) | Cmax po (nM) | Vdss (L/kg) | Cl (mL/min/kg) | t1/2 (h) |
---|---|---|---|---|---|---|
3 | 15 | 0.07 | 60 | 8.1 | 95 | 0.14 |
4 | 4 | 0.06 | 130 | 0.7 | 31 | 0.54 |
5a | 45 | 1.3 | 840 | 1.6 | 15 | 1.6 |
Mouse compound exposures were analyzed in blood; iv and po doses were 1 and 2 mg/kg, respectively.